Amino acid supplement shows promise for rare lung condition
NCT ID NCT03887169
First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This early-phase study tested whether giving methionine (an amino acid) by mouth or feeding tube is safe for children with a rare, severe lung disease caused by a specific gene mutation. The disease leads to breathing problems and has no cure. Only 3 children took part. The main goal was to check for side effects over 75 days, while also watching for any signs of improvement in breathing and lung health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ALVEOLAR PROTEINOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker-Enfants Malades
Paris, Île-de-France Region, 75015, France
Conditions
Explore the condition pages connected to this study.